Position in IART
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,634,209
+$1,143,558 QoQ
Shares Held
173,483
+333.8% QoQ
Ownership
0.223%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
9 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in IART Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026MARSHALL WACE, LLP holds $1,200,961,606 across 58 Medical Devices names. IART ranks #36 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
|
3,611,020 | $226,591,504 | |
| 2 | SYK |
Stryker Corp
|
630,236 | $207,089,246 | |
| 3 | ABT |
Abbott Laboratories
|
2,010,938 | $206,463,003 | |
| 4 | EW |
Edwards Lifesciences Corp
|
1,996,377 | $159,869,868 | |
| 5 | PODD |
Insulet Corp
|
606,482 | $127,264,182 | |
| 6 | GMED |
Globus Medical Inc
|
562,630 | $48,476,200 | |
| 7 | TNDM |
Tandem Diabetes Care Inc
|
1,442,472 | $27,652,186 | |
| 8 | HAE |
Haemonetics Corp
|
320,010 | $18,035,762 |
All Filings in IART
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,634,209 | 173,483 | Shares | Other | 2026-05-15 | |
| 2025-06-30 | $490,651 | 39,988 | Shares | Other | 2025-08-13 | |
| 2024-03-31 | $946,834 | 26,709 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $495,903 | 11,387 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $1,411,884 | 36,970 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $15,229,945 | 370,288 | Shares | Other | 2023-08-14 | |
| 2021-12-31 | $272,180 | 4,063 | Shares | Other | 2022-02-14 | |
| 2020-09-30 | $595,113 | 12,603 | Shares | Sole | 2020-11-16 | |
| 2020-03-31 | $486,322 | 10,887 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||